Dr. Weihua Zhou obtained her PhD in 2012 from the Cancer Center of Sun Yat-Sen University, the best Cancer Institution in China. During her postdoctoral training in Dr. Yi Sun’s lab, she became interested in the field of ubiquitylation and neddylation, especially for the biological functions and regulations of the two neddylation E2s, UBE2M (UBC12) and UBE2F, in lung carcinogenesis. Dr. Zhou was then recruited to the Radiation Oncology Department faculty in 2018, working in Dr. Daniel Wahl’s lab. As a research investigator, she mainly focuses on the abnormal metabolism associating with radioresistance in glioblastoma (GBM).
Areas of Interest
The interactions between radiation and abnormal metabolism in glioblastoma.
- Post-doctoral Fellowship: University of Michigan, 2013-2018, Ann Arbor, MI
- PhD: Sun Yat-Sen University, 2009-2012, Guangzhou, PR. China
- MS: Nanchang University, 2007-2009, Nanchang, PR. China
- BS: Tongji Medical College, Huazhong University of Science and Technology, 2002-2007, Wuhan, PR. China
Selected from 20 publications
- Zhou W, Xu J, Tan M, Li H, Li H, Wei W, Sun Y. UBE2M Is a Stress-Inducible Dual E2 for Neddylation and Ubiquitylation that Promotes Targeted Degradation of UBE2F. Mol Cell. 2018 Jun 21;70(6):1008-1024.e6.
- Zhou HB, Zhou W (co-first aurthor), Zhou B, Liu L, Chern TR, Chinnaswamy K, Lu J, Bernard D, Yang C, Li S, Wang M, Stuckey JA, Sun Y, Wang S. High-Affinity Peptidomimetic Inhibitors of the DCN1-UBC12 Protein-Protein Interaction.J Med Chem. 2018 Feb 13.
- Xu J, Zhou W, Yang F, Chen G, Li H, Zhao Y, Liu P, Li H, Tan M, Xiong X, Sun Y. The β-TrCP-FBXW2-SKP2 axis regulates lung cancer cell growth with FBXW2 acting as a tumour suppressor. Nat Commun. 2017 Jan 16;8:14002.
- Zhou W, Xu J, Li H, Xu M, Chen Z, Wei W, Pan Z, and Sun Y. Neddylation E2 UBE2F Promotes the Survival of Lung Cancer Cells by Activating CRL5 to Degrade NOXA via the K11 Linkage.Clin Cancer Res.2017 Feb 15;23(4):1104-1116.
- Zhou W, Xu J, Zhao Y, Sun Y. SAG/RBX2 is a novel substrate of NEDD4-1 E3 ubiquitin ligase and mediates NEDD4-1 induced chemosensitization. Oncotarget. 2014;5(16):6746-55.